gender identity disorder: A disorder characterized by a strong and persistent cross-gender identification (such as stating a desire to be the other sex or frequently passing as the other sex) coupled with persistent discomfort with his or her sex (manifested in adults, for example, as a preoccupation with altering primary and secondary sex characteristics through hormonal manipulation or surgery).
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
589 |
4. Check minimum number of eventsNone |
589 |
5. Include endpointsNone |
589 |
6. Filter based on genotype QC (FinnGen only) |
561 |
Control definitions (FinnGen only)
- Control exclude
- F5_PERSOBEH
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F63-F69
- Name in latin
- Perturbationes identitatis generis
Similar endpoints
↥List of similar endpoints to
Gender identity disorders
based on the number of shared cases.
Similar with more cases:
- Disorders of adult personality and behaviour
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5826 | 3422 | 2338 |
| Only index persons | 5682 | 3391 | 2291 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.10 | 0.07 |
| Only index persons | 0.11 | 0.12 | 0.09 |
| Median age at first event (years) | |||
| Whole population | 22.20 | 20.84 | 23.99 |
| Only index persons | 22.03 | 20.81 | 23.84 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 561 | 383 | 178 |
| Unadjusted period prevalence (%) | 0.12 | 0.14 | 0.08 |
| Median age at first event (years) | 25.67 | 23.75 | 29.79 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 589
- Matched controls
- 5890
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
21.9
314.6
300
266
IBZ08
NOMESCO Finland
Gender identity assessment
+∞
307.7
408
*
F64.9
ICD-10 Finland
Gender identity disorder, unspecified
4503599627370496.0
307.7
570
*
F64.0
ICD-10 Finland
Transsexualism
8027.2
307.7
364
*
ZY010
NOMESCO Finland
Hospital outpatient
28.9
307.7
324
239
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
55.7
307.7
210
58
121
Kela drug reimbursment
Severe hypofunction of sexual glands
136.7
307.7
167
17
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
18.3
219.9
205
167
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
16.0
205.6
209
196
ZYC01
NOMESCO Finland
Remote contact by phone
14.9
178.9
185
176
Z2445
NOMESCO Finland
Psychologist
13.7
178.0
197
208
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
20.5
160.0
131
81
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
16.7
144.7
132
100
ZYY01
NOMESCO Finland
Contact between professionals
64.1
140.0
78
14
Z3231
NOMESCO Finland
Registered nurse
7.6
137.4
332
853
Z2221
NOMESCO Finland
Medical doctor
7.4
132.4
321
822
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
12.8
130.3
142
143
ZYC02
NOMESCO Finland
Remote contact by video link
175.8
122.6
125
9
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
11.3
117.3
139
157
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
57.0
116.0
66
13
IAB05
NOMESCO Finland
Psychiatric consultation for gender identity assessment
+∞
114.4
106
*
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
45.1
113.4
68
17
N05AH04
ATC
quetiapine; oral
6.4
109.9
285
756
Z2446
NOMESCO Finland
Social worker
9.0
106.6
153
220
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
22.7
104.5
79
40
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
10.7
99.3
120
138
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
13.2
98.7
101
91
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
7.1
95.5
177
335
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
12.7
93.8
98
91
F64.8
ICD-10 Finland
Other gender identity disorders
+∞
93.3
87
*
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
22.6
92.8
70
35
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
46.6
92.6
55
13
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
9.9
89.4
114
140
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
9.0
89.1
123
167
F32.9
ICD-10 Finland
Depressive episode, unspecified
5.5
87.7
244
669
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
53.4
85.0
49
10
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
37.9
83.1
52
15
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
13.5
78.8
78
66
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
34.1
77.5
50
16
G03HA01
ATC
cyproterone; systemic
+∞
75.7
71
*
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
7.5
75.6
123
200
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
25.3
71.4
51
22
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
31.8
71.4
47
16
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
6.5
69.7
133
254
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
8.2
67.8
99
142
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
9.5
67.7
86
104
N06AX12
ATC
bupropion; oral
5.6
65.5
150
339
N06AX16
ATC
venlafaxine; oral
5.2
65.5
168
419
WX402
NOMESCO Finland
General anaesthesia
4.6
63.4
208
630
N05AX12
ATC
aripiprazole; systemic
7.7
63.1
97
147
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
6.8
62.4
110
193
F84.5
ICD-10 Finland
Asperger syndrome
13.9
59.7
57
45
N06AB03
ATC
fluoxetine; oral
5.4
59.4
141
327
G04CB01
ATC
finasteride; oral
12.5
56.8
58
51
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.6
56.7
171
481
N06AB06
ATC
sertraline; oral
4.5
56.4
175
503
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
5.0
50.2
127
308
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.9
49.9
196
663
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
6.2
49.9
94
175
N06AB10
ATC
escitalopram; oral
3.6
49.3
255
1033
F90.0
ICD-10 Finland
Disturbance of activity and attention
4.7
48.9
136
356
N06AX11
ATC
mirtazapine; oral
3.6
48.3
248
998
C03DA01
ATC
spironolactone; oral
7.3
47.9
75
115
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
173.8
46.6
48
*
F40.1
ICD-10 Finland
Social phobias
5.5
44.2
95
199
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
158.2
42.4
44
*
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
6.8
41.7
69
112
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
6.0
41.6
80
151
P76
ICPC
Depressive disorder
4.3
40.9
126
354
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
3.3
40.4
212
849
WVA30, ,
SPAT
8.7
40.3
53
66
IGY99
NOMESCO Finland
Other psychiatric treatment contact
6.8
39.5
66
108
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
16.3
39.4
34
22
N06BA04
ATC
methylphenidate; oral
4.3
37.9
115
318
ZZA50
NOMESCO Finland
Full thickness skin graft
197.0
36.2
37
*
F61.0
ICD-10 Finland
Mixed personality disorders
135.1
36.1
38
*
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
6.1
35.9
66
119
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.3
35.8
64
112
N03AX09
ATC
lamotrigine; oral
5.5
35.7
75
153
ZXE10
NOMESCO Finland
More than one and less than three hours
3.1
35.7
204
850
F32.1
ICD-10 Finland
Moderate depressive episode
4.0
35.7
119
352
N05AX08
ATC
risperidone; systemic
5.3
35.4
77
162
IEY01
NOMESCO Finland
Psychoeducation, individual
14.7
35.0
32
23
SPAT1379
SPAT
Health check-up of pregnant person
0.1
34.1
7
995
N05AH03
ATC
olanzapine; systemic
4.9
32.9
79
181
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
11.2
32.5
35
33
G03DC03
ATC
lynestrenol; oral
7.5
32.3
48
69
N06AX26
ATC
vortioxetine; oral
3.8
31.4
112
345
P09
ICPC
Sexual preference concern
90.1
31.1
34
*
F93.89
ICD-10 Finland
Other childhood emotional disorders
7.1
30.6
48
73
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
3.0
30.5
178
742
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
9.8
30.3
36
39
W78
ICPC
Pregnancy
0.1
29.8
17
1378
IGY02
NOMESCO Finland
Psychiatric monitoring contact
5.0
29.8
68
149
P03
ICPC
Feeling depressed
2.8
28.6
193
866
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
7.1
28.4
44
66
KFC10
NOMESCO Finland
Bilateral orchiectomy
+∞
28.4
27
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
6.5
27.6
47
78
F41.1
ICD-10 Finland
Generalized anxiety disorder
3.4
27.4
117
404
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.1
27.3
20
1346
F64
ICD-10 Finland
Gender identity disorders
+∞
27.3
26
*
P29
ICPC
Psychological sympt/compl other
3.1
27.2
137
522
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
5.6
27.0
54
105
SPAT1243
SPAT
Psychiatric/psychological examination
4.5
26.5
69
168
P01
ICPC
Feeling anxious/nervous/tense
2.5
26.3
258
1383
F34.1
ICD-10 Finland
Dysthymia
5.4
26.1
54
108
N06AB04
ATC
citalopram; systemic
3.4
26.1
109
370
SPAT1307
SPAT
Psychosocial counselling and guidance
2.9
25.8
159
675
IBA03
NOMESCO Finland
Psychotherapy evaluation
7.3
25.8
39
57
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
4.7
25.5
63
147
SPAT1380
SPAT
Postpartum check-up
0.1
25.4
7
798
ICB07, ,
NOMESCO Finland
94.2
24.9
27
*
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.0
24.3
*
605
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
70.5
24.0
27
*
P74
ICPC
Anxiety disorder/anxiety state
3.4
23.7
98
330
N05BA04
ATC
oxazepam; oral
2.7
23.6
163
731
Z32.1
ICD-10 Finland
Pregnancy confirmed
0.1
23.5
*
680
N06AX22
ATC
agomelatine; oral
6.5
23.1
39
64
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
7.1
22.7
35
52
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.1
22.6
12
1069
SPAT1389
SPAT
Visit based on need for special support
3.4
22.3
91
303
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
6.4
22.3
38
63
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.5
22.1
56
133
P99
ICPC
Psychological disorders other
5.0
21.7
49
106
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.1
21.5
12
1034
HAC10
NOMESCO Finland
Subcutaneous mastectomy with preservation of mamilla
52.1
21.3
25
5
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
20.4
21.0
31
16
SPAT1197
SPAT
Extensive health check-up of expecting family
0.1
21.0
14
1048
SPAT1240
SPAT
Therapeutic discussion
2.6
20.9
157
729
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
31.3
20.7
27
9
F60.6
ICD-10 Finland
Anxious [avoidant] personality disorder
114.1
20.7
22
*
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
8.1
20.6
28
36
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
4.3
20.5
56
141
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
0.1
20.5
14
1030
F32
ICD-10 Finland
Depressive episode
3.5
20.4
75
233
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
4.5
20.4
52
124
HAC20
NOMESCO Finland
Total mastectomy
18.1
20.2
31
18
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.1
19.4
7
656
OAA11, ,
SPAT
0.1
19.3
5
609
F31.8
ICD-10 Finland
Other bipolar affective disorders
5.9
19.2
35
62
ZXE20
NOMESCO Finland
More than three and less than five hours
3.6
19.1
68
207
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
7.6
18.8
27
37
IGP01
NOMESCO Finland
Psychiatric family contact
6.3
18.8
32
53
DQW99
NOMESCO Finland
Other operation on larynx
103.4
18.7
20
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.0
18.5
41
87
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
5.4
18.4
37
72
W11
ICPC
Contraception oral
0.3
18.1
71
1724
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
23.7
17.9
25
11
KGC10
NOMESCO Finland
Total amputation of penis
+∞
17.8
17
*
KDH10
NOMESCO Finland
Meatoplasty of urethra
+∞
17.8
17
*
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.1
17.7
10
867
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.3
17.5
30
50
HAB99
NOMESCO Finland
Other partial excision of mammary gland
21.7
17.4
25
12
LEE40
NOMESCO Finland
Construction of vagina
+∞
16.7
16
*
HAC99
NOMESCO Finland
Other mastectomy
+∞
16.7
16
*
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
18.6
16.6
25
14
N06AX21
ATC
duloxetine; oral
3.1
16.3
72
250
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
5.0
16.3
36
76
N06AX05
ATC
trazodone; oral
6.8
16.3
26
40
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.1
16.3
5
535
ZXA10
NOMESCO Finland
Bilateral
2.7
16.1
101
425
F60.9
ICD-10 Finland
Personality disorder, unspecified
49.0
16.1
19
*
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
0.1
16.1
6
551
MA3AE
NOMESCO Finland
Combined first trimester screening
0.1
15.9
5
525
MAX99
NOMESCO Finland
Assistance to normal delivery
0.1
15.9
6
548
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
5.1
15.9
34
70
F33
ICD-10 Finland
Recurrent depressive disorder
4.4
15.8
40
95
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.1
15.6
13
841
F60.8
ICD-10 Finland
Other specific personality disorders
164.2
15.6
16
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.1
15.4
33
68
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
4.3
15.1
40
98
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.1
14.4
13
796
OAA43, ,
SPAT
4.0
14.3
41
107
LFE10
NOMESCO Finland
Plastic repair of vulva
43.6
14.2
17
*
N05AB03
ATC
perphenazine; systemic, rectal
6.0
14.1
25
43
ZY000
NOMESCO Finland
Hospital inpatient
5.7
13.9
26
47
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
0.1
13.7
6
493
IGV01
NOMESCO Finland
Psychiatric network contact
6.1
13.6
24
41
R4120
NOMESCO Finland
Occupational therapy
3.6
13.6
47
140
N06AB05
ATC
paroxetine; oral
4.0
13.4
39
103
N05AN01
ATC
lithium; oral
5.9
13.3
24
42
Z3226
NOMESCO Finland
Physiotherapist
2.4
13.0
97
441
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
0.1
12.7
8
512
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
20.6
12.5
18
9
R4190
NOMESCO Finland
Nutritional therapy
3.7
12.5
40
113
OAA12, ,
SPAT
0.1
12.2
*
408
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
11.4
12.1
22
20
OAA10, ,
SPAT
0.1
12.0
*
405
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.1
11.9
52
179
W90
ICPC
Uncompl labour/delivery livebirth
0.1
11.8
*
400
F39
ICD-10 Finland
Unspecified mood [affective] disorder
4.3
11.7
31
76
HAE99
NOMESCO Finland
Other reconstruction of breast
30.7
11.7
15
5
N05AF03
ATC
chlorprothixene; systemic
10.3
11.6
22
22
DQD32
NOMESCO Finland
Plastic repair vocal cord for better voice
+∞
11.5
11
*
IDY25
NOMESCO Finland
Systematic individual therapy, visual arts psychotherapy
122.3
11.5
12
*
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
0.2
11.2
12
658
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
0.1
11.1
5
403
R49.08
ICD-10 Finland
Other specified dysphonia
10.3
11.1
21
21
N03AG01
ATC
valproic acid; systemic, rectal
3.5
11.0
38
113
F50.9
ICD-10 Finland
Eating disorder, unspecified
4.0
11.0
31
80
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.8
10.9
34
94
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
8.5
10.9
23
28
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
15.9
10.9
17
11
IHZ02, ,
SPAT
2.8
10.9
55
206
F33.8
ICD-10 Finland
Other recurrent depressive disorders
10.9
10.8
20
19
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
0.1
10.8
*
373
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
18.2
10.8
16
9
R4110
NOMESCO Finland
Physiotherapy
2.1
10.7
122
659
F99
ICD-10 Finland
Mental disorder, not otherwise specified
4.4
10.7
27
64
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
0.2
10.6
7
435
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
0.1
10.6
5
390
SPAT1395
SPAT
Health check-up of persons outside student and working life
4.9
10.6
23
48
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
111.9
10.5
11
*
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
8.4
10.4
22
27
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
9.0
10.3
21
24
SPAT1238
SPAT
Brief therapy
3.9
10.3
30
79
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
4.7
10.3
24
53
SPAT1284
SPAT
Extensive health certificate
3.3
10.3
39
123
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.5
10.3
36
108
HA1AA
NOMESCO Finland
X-ray mammography
7.7
10.3
23
31
C07AA05
ATC
propranolol; systemic
2.0
10.2
140
806
A50
ICPC
General and Unspecified, Medication/prescr/renewal
4.3
10.2
26
62
Z37.0
ICD-10 Finland
Single live birth
0.2
10.0
8
436
HWD00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of mammary gland
26.5
9.8
13
5
Y28
ICPC
Limited function/disability (Y)
26.5
9.8
13
5
N62
ICD-10 Finland
Hypertrophy of breast
3.8
9.8
30
82
F41.09
ICD-10 Finland
UNS Panic Syndrome
3.0
9.8
45
160
O80.8
ICD-10 Finland
Other single spontaneous delivery
0.1
9.7
*
297
IER01
NOMESCO Finland
Psychoeducation, group
8.0
9.7
21
27
P06
ICPC
Sleep disturbance
2.2
9.5
93
472
G47.3
ICD-10 Finland
Sleep apnoea
2.4
9.5
72
329
F33.0
ICD-10 Finland
Recurrent depressive disorder, current episode mild
5.3
9.4
19
37
N05AE04
ATC
ziprasidone; systemic
12.6
9.4
16
13
F50.0
ICD-10 Finland
Anorexia nervosa
4.6
9.4
22
49
SPAT1241
SPAT
Extensive assessment of psychosocial situation
3.8
9.3
28
76
N05CF01
ATC
zopiclone; oral
2.1
9.2
94
486
Z30.4
ICD-10 Finland
Surveillance of contraceptive drugs
0.4
9.2
41
990
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
8.5
9.1
19
23
N05BE01
ATC
buspirone; oral
4.9
9.1
20
42
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
37.3
9.0
11
*
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
0.1
9.0
*
279
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
7.6
9.0
20
27
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.9
8.9
26
69
N05BA01
ATC
diazepam; systemic, rectal
2.6
8.8
54
223
ICB06, ,
NOMESCO Finland
9.7
8.8
17
18
N06BA12
ATC
lisdexamfetamine; oral
4.0
8.8
25
65
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
4.0
8.8
25
65
HAD20
NOMESCO Finland
Liposuction of breast
50.8
8.7
10
*
T82
ICPC
Obesity
3.3
8.6
32
100
ZXY03
NOMESCO Finland
Occupational therapist
11.8
8.6
15
13
A55
ICPC
General and Unspecified, Local injection/infiltration
11.8
8.6
15
13
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
0.2
8.6
7
381
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
9.2
8.6
17
19
TQW40
NOMESCO Finland
Remowal of suture of skin
3.2
8.5
34
111
IER05
NOMESCO Finland
Rehabilitative psychiatric group intervention, social skills
28.0
8.5
11
*
F41.8
ICD-10 Finland
Other specified anxiety disorders
2.7
8.5
47
185
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.4
8.5
30
91
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.4
8.5
30
91
QXB10
NOMESCO Finland
Exchange of dressing for large skin wound, unspecified location
91.3
8.4
9
*
N05AD01
ATC
haloperidol; systemic
8.7
8.4
17
20
SPAT1051
SPAT
Guidance regarding sleep disorders
4.5
8.2
20
46
SPA47
NOMESCO Finland
Precision impression for denture
33.8
8.1
10
*
ZXY60
NOMESCO Finland
2-person team, nurses
9.1
8.1
16
18
ZXE22
NOMESCO Finland
Procedure duration at least 4 but less than 5 hours
22.4
8.0
11
5
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
0.1
8.0
*
252
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
13.3
7.9
13
10
ZXY61
NOMESCO Finland
2-person team, special workers
13.3
7.9
13
10
W85
ICPC
Gestational diabetes
0.1
7.9
*
276
SPAT1189
SPAT
Other ultrasound examination during pregnancy
0.0
7.9
*
195
N03AX16
ATC
[U] pregabalin
2.2
7.8
69
336
Z34
ICD-10 Finland
Supervision of normal pregnancy
0.1
7.8
*
250
WZA10, ,
SPAT
2.5
7.7
48
200
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.7
7.7
41
158
N03AE01
ATC
clonazepam; systemic
4.1
7.7
21
53
ZXB10
NOMESCO Finland
Medial
18.6
7.6
11
6
SPAT1234
SPAT
Support of social functional capacity
3.6
7.6
25
72
SPAT1308
SPAT
Sexual health counselling
0.6
7.6
116
1813
P86
ICPC
Anorexia nervosa/bulimia
6.6
7.5
18
28
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
6.1
7.4
19
32
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.7
7.4
155
1009
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
8.5
7.4
15
18
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.9
7.4
35
127
N05AA02
ATC
levomepromazine; systemic
4.2
7.3
19
46
LED01
NOMESCO Finland
Laparoscopic vaginectomy
+∞
7.3
7
*
Z29
ICPC
Social problem NOS
3.3
7.2
27
85
O48
ICD-10 Finland
Prolonged pregnancy
0.0
7.2
*
176
SPAT1196
SPAT
Monitoring of normal pregnancy
0.1
7.0
*
274
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
6.0
7.0
18
31
SPAT1195
SPAT
Antenatal classes
0.0
6.9
*
199
F60.5
ICD-10 Finland
Anankastic personality disorder
8.4
6.9
14
17
OAA70, ,
SPAT
0.0
6.8
*
167
M79.7
ICD-10 Finland
Fibromyalgia
3.6
6.8
22
63
F44.88
ICD-10 Finland
Other definite dissociation disorder
40.5
6.8
8
*
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
22.8
6.7
9
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.0
6.7
29
100
F41.3
ICD-10 Finland
Other mixed anxiety disorders
2.9
6.6
30
106
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
10.2
6.6
12
12
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
5.4
6.5
18
34
F31
ICD-10 Finland
Bipolar affective disorder
5.8
6.5
17
30
SPAT1139
SPAT
Nutrition survey
3.6
6.5
21
60
HAD35
NOMESCO Finland
Reduction mammoplasty with transplantation of areola
70.6
6.4
7
*
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
6.7
6.4
15
23
W84
ICPC
Pregnancy high risk
0.1
6.4
*
234
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
11.2
6.3
11
10
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
9.4
6.3
12
13
O99.80
ICD-10 Finland
The fear of childbirth
0.2
6.3
6
294
TQW20
NOMESCO Finland
Tatoe
18.2
6.3
9
5
F41.08
ICD-10 Finland
Mild or other specified panic syndrome
7.1
6.2
14
20
P80
ICPC
Personality disorder
27.0
6.2
8
*
N02BF02
ATC
pregabalin; oral
3.0
6.2
27
93
SPAT1200
SPAT
Guidance for breast-feeding and breast care
0.0
6.2
*
156
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.4
6.2
22
67
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
12.7
6.1
10
8
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
6.8
6.1
14
21
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
10.2
6.1
11
11
O81.4
ICD-10 Finland
Vacuum extractor delivery
0.2
6.0
*
250
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
175
338
6.94
92.35
2.3
1.9
10.28
11.75
nmol/l
0.82
155
312
100
150
7.83
65.77
2.2
1.7
0.26
0.34
nmol/l
0.86
90
132
358
4833
0.34
33.94
3.3
4.1
—
—
—
0
0
130
435
3.55
32.28
1.9
1.6
351.91
306.75
mu/l
1.28
121
382
96
317
3.42
23.94
1.9
1.6
6.81
8.21
u/l
0.81
76
255
172
793
2.65
23.56
1.7
1.6
1.42
1.31
%
1.71
159
722
11
990
0.09
20.70
1.0
1.5
—
—
—
0
0
86
299
3.20
19.57
2.0
1.5
4.90
13.16
iu/l
7.18
70
233
6
631
0.09
19.23
1.2
1.4
—
—
—
0
0
156
756
2.45
18.73
1.6
1.5
1.40
1.27
mmol/l
1.02
139
680
6
526
0.10
14.98
1.0
1.5
—
—
—
0
0
455
3590
2.18
14.01
3.7
3.5
14.39
14.41
pmol/l
0.07
407
3228
5
463
0.10
13.40
1.0
1.4
—
—
—
0
0
5
464
0.10
13.39
1.0
1.4
—
—
—
0
0
5
464
0.10
13.39
1.0
1.5
—
—
—
0
0
5
464
0.10
13.39
1.0
1.5
—
—
—
0
0
5
432
0.11
12.15
1.0
1.5
—
—
—
0
0
145
2250
0.53
10.00
2.4
2.9
0.00
0.00
estimate
-0.00
33
487
146
2236
0.54
9.46
2.4
2.8
0.00
0.00
estimate
-0.00
33
501
146
2228
0.54
9.30
3.3
3.9
0.00
0.00
estimate
0.50
36
502
30
93
3.35
8.18
1.7
1.7
—
—
—
0
0
150
960
1.75
7.60
2.0
2.4
2.36
2.36
mmol/l
0.09
137
858
111
1741
0.55
7.27
2.3
2.8
—
—
—
0
0
56
1092
0.46
7.22
1.1
1.5
—
—
—
0
0
185
1278
1.65
6.99
3.4
2.6
28.78
28.02
u/l
0.19
169
1211
156
2202
0.60
6.69
1.9
2.5
—
—
—
0
0
8
333
0.23
6.29
1.9
1.9
—
—
—
0
0
87
1401
0.56
6.04
2.0
2.1
—
—
—
0
0
473
4163
1.69
6.00
4.6
4.0
1.92
1.78
mu/l
1.29
442
3923
149
2068
0.63
5.67
1.8
1.8
—
—
—
0
0
17
36
4.83
5.65
3.0
2.4
36747.06
39330.89
ug/l
0.44
17
36
419
4687
0.63
5.64
7.4
8.6
15.49
20.62
mg/l
3.28
245
3455
147
2040
0.63
5.56
1.9
2.4
—
—
—
0
0
138
947
1.60
5.16
2.6
3.2
9.08
9.16
mmol/l
0.04
114
871
208
2631
0.68
4.81
2.4
2.8
52.73
56.71
ug/l
0.32
184
2475
40
760
0.49
4.64
1.5
2.3
218.04
5459.74
u/l
—
7
291
26
573
0.43
4.52
1.5
1.4
—
—
—
0
0
74
1161
0.59
4.49
1.9
1.9
—
—
—
0
0
153
2018
0.67
4.23
2.0
2.4
—
—
—
0
0
27
549
0.47
3.80
1.6
1.9
—
—
—
0
0
348
3010
1.38
3.58
3.3
3.2
35.28
36.17
mmol/mol
0.86
323
2855
78
514
1.60
3.42
1.3
1.4
435.60
14347314.43
pmol/l
0.50
57
467
11
27
4.13
3.41
1.0
1.7
8.33
6.62
nmol/l
0.52
11
27
524
5479
0.60
3.36
12.1
12.1
138.51
136.39
g/l
3.22
506
5403
85
1212
0.65
3.33
2.5
3.0
0.00
0.01
estimate
1.08
33
486
524
5475
0.61
3.24
12.0
12.0
4.68
4.61
e12/l
2.99
475
5329
7
11
6.42
3.19
1.3
2.2
1.81
1.94
nmol/l
—
7
11
65
417
1.63
3.18
2.4
2.2
2.40
2.39
mmol/l
0.12
57
362
524
5468
0.62
3.04
12.0
12.0
41.64
41.44
%
0.09
494
5219
62
929
0.63
3.03
2.1
1.9
—
—
—
0
0
49
297
1.71
2.98
2.2
2.2
—
—
—
0
0
416
3757
1.37
2.96
3.2
2.7
2.84
2.73
mmol/l
1.65
380
3556
524
5464
0.63
2.93
12.0
12.1
269.47
261.10
e9/l
1.63
476
5314
411
3722
1.34
2.75
3.1
2.6
1.30
1.44
mmol/l
11.33
377
3538
197
1609
1.34
2.74
2.2
2.3
57.76
68.16
nmol/l
6.82
175
1501
56
362
1.60
2.68
1.5
1.6
1139.66
1114.05
nmol/l
0.07
41
281
412
3748
1.33
2.57
3.2
2.7
4.48
4.53
mmol/l
0.52
380
3572
5
159
0.31
2.45
1.4
1.6
—
—
—
0
0
84
606
1.45
2.44
1.3
1.3
18.34
19.30
nmol/l
0.31
72
533
27
467
0.56
2.34
1.6
1.7
—
—
—
0
0
5
149
0.33
2.17
1.4
2.0
—
—
—
0
0
141
1134
1.32
2.12
1.6
1.5
88.20
97.68
pmol/l
1.73
81
632
152
1238
1.31
2.09
3.4
4.5
38.65
38.33
g/l
0.28
134
1158
11
247
0.43
2.08
1.0
1.3
—
—
—
0
0
35
540
0.63
1.97
1.1
1.3
—
—
—
0
0
9
197
0.45
1.87
1.3
1.5
—
—
—
0
0
398
3674
1.26
1.84
3.1
2.5
5.59
5.45
mmol/l
0.93
361
3402
441
4137
1.26
1.68
7.5
7.5
139.72
139.43
mmol/l
2.29
415
3982
63
838
0.72
1.67
1.6
1.9
0.47
0.83
mg/l
2.81
40
557
147
1227
1.26
1.65
4.3
5.4
1.23
1.22
mmol/l
0.82
131
1132
87
1087
0.77
1.51
2.0
2.1
2.93
2.63
mg/l
0.65
67
935
440
4147
1.24
1.49
7.5
7.5
3.81
3.88
mmol/l
5.67
413
3973
72
919
0.75
1.46
2.3
2.3
40.77
20.96
ng/l
0.31
25
329
160
1368
1.23
1.44
4.0
6.0
1.22
1.22
mmol/l
0.55
133
1175
13
66
1.99
1.44
1.1
2.7
0.90
0.93
nmol/l
0.06
13
59
0
41
0.00
1.31
0.0
1.2
—
—
—
0
0
6
134
0.44
1.29
1.0
1.1
—
—
—
0
0
12
216
0.55
1.27
1.2
1.3
—
—
—
0
0
19
297
0.63
1.19
1.4
1.5
—
—
—
0
0
0
35
0.00
1.15
0.0
1.1
—
1.05
—
0
15
19
293
0.64
1.13
1.4
1.5
—
—
—
0
0
50
640
0.76
1.06
2.1
2.5
345.79
4086.87
umol/l
1.78
42
591
8
148
0.53
1.05
1.6
2.2
0.14
0.15
e6/l
—
8
139
445
4252
1.19
1.04
10.4
10.0
13.23
13.59
%
2.51
429
4162
0
31
0.00
0.96
0.0
2.0
—
—
—
0
0
7
37
1.90
0.94
1.0
1.9
0.00
0.00
g/l
—
7
37
7
37
1.90
0.94
1.0
1.9
0.00
0.00
g/l
—
7
37
375
3549
1.16
0.94
2.7
2.5
1.27
1.16
mmol/l
1.85
346
3363
8
146
0.54
0.93
1.0
1.1
—
—
—
0
0
12
195
0.61
0.92
1.3
1.2
—
—
—
0
0
105
1212
0.84
0.90
2.6
2.9
—
—
—
0
0
45
569
0.77
0.89
2.3
2.2
0.90
1.26
e6/l
0.59
21
295
13
205
0.63
0.89
2.0
2.1
98.00
86.62
ml/min/173m2
—
7
73
291
2715
1.14
0.87
5.2
5.7
78.09
72.19
u/l
1.58
260
2543
90
1050
0.83
0.87
2.1
2.3
54.11
56.10
u/l
0.23
76
974
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
233
2515
0.88
0.81
7.5
7.2
3.86
3.88
e9/l
0.05
200
2192
13
199
0.65
0.79
2.0
1.4
—
—
—
0
0
0
26
0.00
0.78
0.0
1.2
—
95.00
—
0
13
0
26
0.00
0.78
0.0
1.5
—
—
—
0
0
0
27
0.00
0.77
0.0
1.0
—
94.14
—
0
14
204
2214
0.88
0.77
4.4
5.3
54.47
55.18
%
0.47
186
2100
38
300
1.29
0.73
3.4
3.4
5.02
4.76
pmol/l
0.77
32
268
208
2246
0.89
0.71
4.5
5.5
31.95
31.17
%
0.58
191
2132
7
40
1.76
0.71
1.0
1.9
41.54
40.17
g/l
—
7
40
9
143
0.62
0.70
1.0
1.1
—
—
—
0
0
9
143
0.62
0.70
1.1
1.6
—
—
—
0
0
7
41
1.72
0.70
1.0
1.8
0.00
0.00
g/l
—
7
41
7
43
1.64
0.67
1.0
1.8
0.00
0.74
g/l
—
7
43
45
546
0.81
0.66
2.2
2.3
9.00
4.93
e6/l
0.56
22
273
7
44
1.60
0.65
1.0
1.8
11.01
9.80
g/l
—
7
44
7
44
1.60
0.65
1.0
1.8
2.90
2.91
g/l
—
7
44
7
44
1.60
0.65
1.1
1.0
—
—
—
0
0
8
51
1.58
0.60
1.0
1.1
—
—
—
0
0
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.4
—
—
—
0
0
26
202
1.30
0.58
2.5
3.7
1.02
0.46
mmol/l
0.68
18
132
8
54
1.49
0.57
1.0
1.1
—
—
—
0
0
88
990
0.87
0.57
2.4
2.6
0.18
0.21
e6/l
0.18
60
727
8
123
0.65
0.55
2.4
1.6
—
232.00
—
0
5
32
258
1.25
0.55
3.4
5.1
1.70
1.17
mmol/l
0.32
26
196
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
6
39
1.54
0.53
1.0
1.1
—
—
—
0
0
6
40
1.51
0.51
1.0
1.1
—
—
—
0
0
6
40
1.51
0.51
1.0
1.1
—
—
—
0
0
6
40
1.51
0.51
1.0
1.1
—
—
—
0
0
34
411
0.82
0.51
2.1
3.3
1.01
1.50
ug/l
1.32
26
375
482
4714
1.12
0.49
7.3
6.7
26.67
25.40
u/l
0.69
455
4551
25
199
1.27
0.48
3.2
2.3
1.23
1.23
mmol/l
0.05
18
175
7
47
1.50
0.47
1.0
1.7
7.66
7.19
g/l
—
7
47
7
47
1.50
0.47
1.0
1.7
—
—
—
0
0
7
47
1.50
0.47
1.0
1.7
4.17
3.43
g/l
—
7
47
27
218
1.25
0.47
4.6
6.9
1.30
1.32
mmol/l
0.05
27
210
7
49
1.43
0.46
1.0
1.1
—
—
—
0
0
7
49
1.43
0.46
1.0
1.1
228.43
210.89
mg/l
—
7
44
5
84
0.59
0.46
1.2
1.8
6.80
6.82
mmol/l
—
5
76
12
164
0.73
0.45
9.1
11.8
123.17
126.26
g/l
0.23
12
156
10
141
0.70
0.45
3.3
3.6
157.00
159.48
%
—
10
135
39
330
1.19
0.45
2.4
2.4
29.29
32.36
%
0.82
28
250
11
78
1.42
0.43
2.5
2.9
69.84
34.47
mu/l
0.36
11
71
5
31
1.62
0.43
1.0
1.1
210.40
193.29
iu/ml
—
5
31
31
258
1.21
0.42
1.2
1.4
—
—
—
0
0
39
333
1.18
0.42
2.9
2.3
27.27
29.71
u/l
0.52
33
272
0
15
0.00
0.41
0.0
2.0
—
2.65
—
0
15
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
17
0.00
0.40
0.0
2.6
—
—
—
0
0
0
17
0.00
0.40
0.0
2.6
—
—
—
0
0
40
463
0.85
0.40
1.6
2.6
21.07
1024.21
ng/l
1.60
15
200
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
53.99
—
0
19
5
77
0.65
0.36
8.8
2.3
6754.00
233.74
ug/l
—
5
70
36
412
0.87
0.33
2.0
2.2
22.93
24.43
%
0.25
30
368
41
463
0.88
0.31
1.8
2.1
2.50
2.56
g/l
0.33
33
422
7
99
0.70
0.31
1.0
1.1
—
—
—
0
0
7
53
1.32
0.31
1.4
1.2
—
—
—
0
0
155
1630
0.93
0.29
4.4
4.4
9.69
10.33
umol/l
0.69
135
1514
32
282
1.14
0.26
2.3
2.2
—
20.06
—
0
20
25
216
1.16
0.26
1.4
1.7
—
—
—
0
0
5
40
1.25
0.22
1.2
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
2.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
3.4
—
23.58
—
0
12
0
12
0.00
0.21
0.0
1.0
—
95.63
—
0
12
0
12
0.00
0.21
0.0
1.0
—
25.25
—
0
12
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
13
108
1.21
0.20
1.1
1.2
—
—
—
0
0
6
50
1.20
0.19
1.2
1.5
—
—
—
0
0
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
15
127
1.19
0.19
1.2
1.7
—
—
—
0
0
5
68
0.73
0.17
1.4
1.3
—
—
—
0
0
12
101
1.19
0.16
1.0
1.3
3.68
3.53
mmol/l
0.60
12
95
8
71
1.13
0.16
1.1
1.4
—
—
—
0
0
8
71
1.13
0.16
1.1
1.4
—
—
—
0
0
47
503
0.93
0.16
1.2
1.2
109.00
129.78
iu/ml
0.18
15
182
102
980
1.05
0.14
2.0
2.9
1.02
1.02
kg/l
—
5
138
9
83
1.09
0.14
1.1
1.3
—
—
—
0
0
13
113
1.15
0.13
1.2
1.5
403.15
464.45
mg/l
0.31
13
108
9
110
0.82
0.13
1.7
3.0
28.33
52.81
ng/l
—
9
95
104
1077
0.96
0.13
6.8
6.1
1.04
1.08
inr
0.80
53
405
34
319
1.07
0.10
4.9
4.0
—
—
—
0
0
20
183
1.10
0.10
1.1
1.1
3.37
2.53
u/ml
0.15
12
101
44
463
0.95
0.10
1.2
1.0
—
—
—
0
0
51
534
0.95
0.10
3.6
4.4
7.32
17.17
mg/mmol
1.25
30
393
5
45
1.11
0.10
1.2
1.4
—
—
—
0
0
5
46
1.09
0.09
3.0
1.8
—
—
—
0
0
5
46
1.09
0.09
1.6
1.3
48.92
180.66
pmol/l
—
5
46
38
399
0.95
0.08
3.1
2.8
5.40
6.62
umol/l
0.35
28
327
18
195
0.92
0.08
1.0
1.1
15.02
9.01
u/ml
0.36
13
122
62
642
0.96
0.08
1.3
1.2
19.81
7.80
u/ml
0.40
18
257
22
205
1.08
0.08
1.2
1.4
—
—
—
0
0
9
84
1.07
0.07
1.1
1.3
—
1.57
—
0
11
295
2978
0.98
0.07
3.0
3.4
7.72
7.50
mm/h
0.15
259
2752
68
665
1.03
0.04
1.4
1.2
16.42
16.21
iu/ml
0.02
17
184
22
209
1.05
0.04
1.2
1.6
—
—
—
0
0
23
241
0.95
0.04
1.8
2.2
0.37
0.65
ug/l
2.44
11
117
388
3862
1.01
0.04
6.6
6.6
106.49
105.59
ml/min/173m2
0.33
256
2911
312
3102
1.01
0.04
3.2
2.5
37.54
29.34
u/l
1.25
288
2974
17
179
0.95
0.03
1.2
1.4
—
—
—
0
0
19
199
0.95
0.03
1.2
1.4
136.30
207.10
u/ml
—
10
103
27
279
0.97
0.02
7.8
6.9
104.41
105.15
mmol/l
0.24
27
279
21
202
1.04
0.02
4.3
6.8
25.30
24.58
mmol/l
0.47
21
202
11
103
1.07
0.02
2.5
3.5
0.65
0.72
%
0.22
11
103
157
1561
1.01
0.01
1.5
1.4
1.03
1.88
u/ml
0.92
31
396
12
114
1.05
0.00
1.1
1.3
—
56.81
—
0
10
12
126
0.95
0.00
1.1
1.1
—
10.18
—
0
11
16
165
0.97
0.00
1.4
2.1
36.29
24.88
u/ml
0.72
16
159
10
103
0.97
0.00
2.5
4.2
57.40
53.82
%
—
10
103
10
103
0.97
0.00
2.5
4.0
4.22
3.50
e9/l
—
10
103
10
98
1.02
0.00
1.1
1.3
48.00
42.60
pmol/l
—
10
93
74
743
1.00
0.00
1.7
2.0
153.61
315.77
u/l
0.81
62
715
207
2075
1.00
0.00
3.3
4.0
6.13
6.10
mmol/l
0.06
191
1797
8
79
1.01
0.00
1.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
8
86
0.93
-0.00
2.0
3.4
52.06
52.26
%
—
8
86
0
9
0.00
-0.00
0.0
1.0
—
181.00
—
0
9
0
8
0.00
-0.00
0.0
1.3
—
21.14
—
0
8
9
91
0.99
-0.00
1.0
1.3
—
6.58
—
0
8
7
69
1.01
-0.00
1.1
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
22
220
1.00
-0.00
1.1
1.1
4.39
3.67
u/ml
0.06
12
120
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.7
—
0.83
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
0.43
—
0
6
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
589.22
—
0
9
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
5
55
0.91
-0.00
1.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
5.9
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
5.06
—
0
7
0
7
0.00
-0.00
0.0
5.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
55
0.91
-0.00
1.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
4.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
69
1.01
-0.00
1.1
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
1.21
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
73
0.96
-0.00
2.4
1.6
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_GENDER and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have F5_GENDER.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: F5_GENDER – Gender identity disorders
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data